Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Preceptorship on Advanced Non Resectable Hepatocellular Carcinoma, Biliary and Pancreatic Cancer Paris December 2019

06 - 07 Dec 2019

Paris, France

ESMO-Preceptorship-Hereditary-Cancer-Genetics-1000x1000

Slides and Webcasts from all ESMO Preceptorships are open to all ESMO account holders, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties.

Learning Objectives
  • To understand epidemiology, aetilology and molecular pathology of Hepatocellular Carcinoma (HCC), Biliary and Pancreatic Cancers
  • To understand multidisciplinary management and treatment of advanced non resectable HCC, Biliary and Pancreatic Cancers
  • To learn about advances in treatment and novel targets in Hepatobiliary (HPB) Carcinomas
  • To address complex cases management frequently encountered in daily practice, related with these diseases

This event has been supported by an unrestricted educational grant from MSD.​

Hide
Filter by:

There are 26 resources available

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.